Pluristem Therapeutics Inc (PSTI)

[zzaatt]

It is interesting to note (as some have noted on this board) that Pluristem will be a huge success if it does nothing but produce good results for CLI.

On the other hand, there's good reason to hope that the Covid target will turn out as well, and in that case we have a huge multiplier effect.

Here's why I think our Covid chances are good:

1. It just happens that PLX-PAD does the sort of things it needs to do to modulate the immune response, and provide support for the organs that are under attack by the virus. In other words, there's good scientific rationale for expecting efficacy, based on many years of experience with stem cells (and I don't mean JUST Pluristem).

2. Many other organizations that work with stem cells have the same sort of expectations. In other words there's a general consensus as reflected by other significant (commercial) efforts using the same technology.

3. We have had some clinical feedback already. Yes, it was a small sample, but very strong results. Could it be coincidence? Maybe, but not likely.

I would rephrase the "High Risk, High Reward Play" to "Moderate Risk, High Reward Play"